Document Detail

Walnut consumption in hyperlipidemic patients.
MedLine Citation:
PMID:  16193197     Owner:  NLM     Status:  MEDLINE    
Walnut (Juglans regia L.) is described as an anticancer, tonic, blood purifier, and detoxifier agent. It is said that nuts have favorable fatty acids and nutrients. This study was performed to determine the lipid-lowering properties of walnut in a population in Shiraz, Southern Iran. In a randomized case-control study, 52 volunteers were divided into 2 groups: Group A consumed walnuts, 20 grams per day for 8 weeks and the control group (group B) consumed no walnuts. Triglycerides, total high-density lipoprotein (HDL), and low-density lipoprotein (LDL) levels were checked for each subject prior to, after 4 weeks, and at 8 weeks after the beginning of the study. In group A, the mean plasma TG level dropped by 17.1% from the baseline and HDL cholesterol also increased significantly by 9%. It was shown that frequent consumption of nuts in the daily diet was associated with a potentially decreased risk of coronary artery disease by decreasing the level of triglyceride and increasing the level of HDL.
M J Zibaeenezhad; S J Shamsnia; M Khorasani
Related Documents :
8302497 - New recommendations for the diagnosis and treatment of plasma lipid abnormalities.
19801067 - Increased participation in activities of daily living is associated with lower choleste...
10399057 - Comparison of the effects of conjugated estrogen treatment on blood lipid and lipoprote...
3207437 - Effects of bezafibrate and gemfibrozil on serum lipoproteins in primary hypercholestero...
10985417 - Effects of degree of fat saturation on fiber digestion and microbial protein synthesis ...
6794547 - Serum reserve cholesterol binding capacity (srcbc): the relative importance of differen...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Angiology     Volume:  56     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:    2005 Sep-Oct
Date Detail:
Created Date:  2005-09-29     Completed Date:  2005-11-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  581-3     Citation Subset:  IM    
Cardiovascular Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Coronary Artery Disease / prevention & control
Hyperlipidemias / drug therapy*
Plant Preparations / therapeutic use*
Risk Factors
Treatment Outcome
Reg. No./Substance:
0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Plant Preparations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The glucose tolerance test, but not HbA(1c), remains the gold standard in identifying unrecognized d...
Next Document:  Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?